🔗 Visit the ClinicalTrials.gov page for NCT00722137
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. | N Engl J Med | 2015 | 3.18 |
| 2 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2012 | 1.33 |
| 3 | Targeted therapy in lymphoma. | J Hematol Oncol | 2010 | 1.05 |
| 4 | Haematological cancer: Bortezomib in MCL--new standard of care or just another option? | Nat Rev Clin Oncol | 2015 | 0.75 |